Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension

PURPOSE: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Topouzis, Fotis, Goldberg, Ivan, Bell, Katharina, Tatham, Andrew J, Ridolfi, Antonia, Hubatsch, Douglas, Nicolela, Marcelo, Denis, Phillipe, Lerner, S Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859663/
https://www.ncbi.nlm.nih.gov/pubmed/31595773
http://dx.doi.org/10.1177/1120672119878044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859663/
https://www.ncbi.nlm.nih.gov/pubmed/31595773
http://dx.doi.org/10.1177/1120672119878044

Ejemplares similares